Comments
Loading...

Reshape Lifesciences Earnings Estimates

RSLSNASDAQ
Logo brought to you by Benzinga Data
$1.00
-0.03-2.90%

Reshape Lifesciences Earnings Estimates, EPS & Revenue | NASDAQ:RSLS | Benzinga

Reshape Lifesciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 14
EPS
$-3.110
Quarterly Revenue
$2.29M
Annual Revenue
(as of Sep 30)
$8.18M

Analyze the earnings history of Reshape Lifesciences using advanced sorting and filters.

Data brought to you by Benzinga APIs

Reshape Lifesciences (RSLS) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q12024-05-15$-5.22$-9.2843.8 %
Q32023-11-08$-59.16$-69.6015.0 %
Q22023-08-07$-62.64$-103.8239.7 %
Q12023-05-15$-90.48$-244.1862.9 %

Reshape Lifesciences (RSLS) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q32024-11-14$2.29M$2.51M-8.69 %
Q22024-08-14$1.97M$2.21M-11.1 %
Q12024-05-15$1.94M$2.10M-7.43 %
Q32023-11-08$2.15M$2.40M-10.2 %

FAQ

Q

When is Reshape Lifesciences (NASDAQ:RSLS) reporting earnings?

A

Reshape Lifesciences (RSLS) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Reshape Lifesciences (NASDAQ:RSLS)?

A

The Actual EPS was $-3.11, which missed the estimate of $0.00.

Q

What were Reshape Lifesciences’s (NASDAQ:RSLS) revenues?

A

The Actual Revenue was $2.3M, which missed the estimate of $2.5M.

Browse earnings estimates, EPS, and revenue on all stocks.